Pacira Biosciences
PCRX
#5936
Rank
HK$7.60 B
Marketcap
HK$176.80
Share price
2.50%
Change (1 day)
-3.86%
Change (1 year)
Categories

Market capitalization of Pacira Biosciences (PCRX)

Market cap: HK$7.60 Billion

As of March 2026 Pacira Biosciences has a market cap of HK$7.60 Billion. This makes Pacira Biosciences the world's 5936th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Pacira Biosciences from 2011 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$7.60 B-17.93%
2025HK$9.26 B31.58%
2024HK$7.04 B-42.44%
2023HK$12.23 B-11.59%
2022HK$13.84 B-33.77%
2021HK$20.89 B3.7%
2020HK$20.15 B36.31%
2019HK$14.78 B6.47%
2018HK$13.88 B-4.02%
2017HK$14.46 B54.46%
2016HK$9.36 B-57.28%
2015HK$21.93 B-11.78%
2014HK$24.86 B65.79%
2013HK$14.99 B239.44%
2012HK$4.41 B281.65%
2011HK$1.15 B

End of Day market cap according to different sources

On Mar 18th, 2026 the market cap of Pacira Biosciences was reported to be:

HK$6.98 Billion
by Nasdaq info icon info icon
HK$7.42 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Zogenix
ZGNX
HK$11.75 B 54.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
HK$0.96 B-87.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
HK$6.06 B-20.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
HK$3.59 B-52.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
HK$1.19 B-84.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
HK$63.53 M-99.16%๐Ÿ‡บ๐Ÿ‡ธ USA